Q3 2016 EPS Estimates for Acadia Healthcare Co. (ACHC) Decreased by Analyst
Acadia Healthcare Co. (NASDAQ:ACHC) – Stock analysts at KeyCorp cut their Q3 2016 earnings estimates for shares of Acadia Healthcare in a research note issued to investors on Monday. KeyCorp analyst J. Gurda now expects that the brokerage will earn $0.66 per share for the quarter, down from their prior forecast of $0.68. KeyCorp also issued estimates for Acadia Healthcare’s FY2016 earnings at $2.57 EPS, FY2017 earnings at $3.06 EPS and FY2018 earnings at $3.79 EPS.
Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Friday, July 29th. The company reported $0.73 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.73. Acadia Healthcare had a return on equity of 9.35% and a net margin of 6.44%. The firm had revenue of $756.50 million for the quarter, compared to analyst estimates of $752.57 million. During the same period in the previous year, the company posted $0.57 earnings per share. The company’s quarterly revenue was up 66.8% compared to the same quarter last year.
Several other equities analysts also recently commented on the stock. Royal Bank Of Canada lowered their target price on shares of Acadia Healthcare from $86.00 to $78.00 and set an “outperform” rating on the stock in a report on Monday, August 1st. Leerink Swann reissued a “buy” rating and issued a $80.00 target price on shares of Acadia Healthcare in a report on Sunday, August 28th. Jefferies Group reissued a “buy” rating and issued a $85.00 target price on shares of Acadia Healthcare in a report on Monday, June 27th. RBC Capital Markets reissued an “outperform” rating and issued a $78.00 target price (down previously from $86.00) on shares of Acadia Healthcare in a report on Monday, August 1st. Finally, Robert W. Baird lowered their target price on shares of Acadia Healthcare from $67.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday, September 15th. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $77.21.
Shares of Acadia Healthcare (NASDAQ:ACHC) traded up 1.80% during trading on Tuesday, reaching $44.22. The company had a trading volume of 321,548 shares. The company has a market cap of $3.87 billion, a price-to-earnings ratio of 23.62 and a beta of 0.86. Acadia Healthcare has a 12 month low of $42.47 and a 12 month high of $74.77. The firm has a 50 day moving average price of $49.16 and a 200 day moving average price of $54.58.
In other news, major shareholder Waud Capital Partners Iii, L.L sold 457,443 shares of the business’s stock in a transaction on Friday, September 16th. The shares were sold at an average price of $48.39, for a total transaction of $22,135,666.77. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Ronald Morgan Fincher sold 8,800 shares of the company’s stock in a transaction dated Monday, August 8th. The stock was sold at an average price of $52.56, for a total transaction of $462,528.00. Following the completion of the sale, the chief operating officer now directly owns 120,780 shares of the company’s stock, valued at $6,348,196.80. The disclosure for this sale can be found here. Insiders own 17.20% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the company. Advisory Services Network LLC raised its stake in Acadia Healthcare by 5,542.1% in the third quarter. Advisory Services Network LLC now owns 2,144 shares of the company’s stock worth $106,000 after buying an additional 2,106 shares during the period. American International Group Inc. raised its stake in Acadia Healthcare by 71.7% in the second quarter. American International Group Inc. now owns 2,218 shares of the company’s stock worth $123,000 after buying an additional 926 shares during the period. Advisor Group Inc. acquired a new stake in Acadia Healthcare during the second quarter worth $166,000. Springbok Capital Management LLC raised its stake in Acadia Healthcare by 101.3% in the first quarter. Springbok Capital Management LLC now owns 3,741 shares of the company’s stock worth $206,000 after buying an additional 1,883 shares during the period. Finally, Jane Street Group LLC acquired a new stake in Acadia Healthcare during the second quarter worth $210,000.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico.
Receive News & Stock Ratings for Acadia Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Co. and related stocks with our FREE daily email newsletter.